Learn more about whether Alnylam Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ ...

In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...

As the Houston region positions itself to become a national hub for pharmaceutical manufacturing, San Jacinto College is ...

Swiss pharmaceutical giant Roche has agreed to acquire US biotech firm 89bio, a developer of therapies for liver and cardiometabolic diseases, in a transaction valued at up to about $3. 5 billion.

Innovative Pharmaceutical Biotech ( ($HK:0399) ) just unveiled an announcement. Innovative Pharmaceutical Biotech Limited has announced a further ...

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is one of the best affordable biotech stocks to invest in now . Rigel ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

A Madison, Wisconsin-based biotech with offices in Cambridge announced an $8 million seed round and a continuing partnership ...

LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron ...

Deal to foster Roche's activities to build 'robust,' differentiated pipeline that targets additional causes of metabolic disease - Anadolu Ajansı ...

Funds from the US are flowing into biotech ETFs as investors seek unique opportunities to beat the market, China AMC’s Heidi Cai says.